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cellular function, its precise biological role is not fully understood. Runx1 gene, which encodes a
transcription factor implicated in hematopoiesis, angiogenesis, and leukemogenesis, contains IRES sequences
in the 5′ untranslated region. To clarify the roles of the IRES element in Runx1 function, we generated knock-
in mice for either wild-type Runx1 or Runx1/Evi1, a Runx1 fusion protein identiﬁed in human leukemia. In
both cases, native promoter-dependent transcription was retained, whereas IRES-mediated translation was
eliminated. Interestingly, homozygotes expressing wild-type Runx1 deleted for the IRES element
(Runx1ΔIRES/ΔIRES) died in utero with prominent dilatation of peripheral blood vessels due to impaired
pericyte development. In addition, hematopoietic cells in the Runx1ΔIRES/ΔIRES fetal liver were signiﬁcantly
decreased, and exhibited an altered differentiation pattern, a reduced proliferative activity, and an impaired
reconstitution ability. On the other hand, heterozygotes expressing Runx1/Evi1 deleted for the IRES element
(Runx1+/REΔIRES) were born normally and did not show any hematological abnormalities, in contrast that
conventional Runx1/Evi1 heterozygotes die in utero with central nervous system hemorrhage and Runx1/
Evi1 chimeric mice develop acute leukemia. The ﬁndings reported here demonstrate the essential roles of the
IRES element in Runx1 function under physiological and pathological conditions.+81 82 257 1556.
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Regulation of protein synthesis plays an essential role in the
control of proper gene expression. In eukaryotic cells, there are two
major mechanisms for translation initiation; i) conventional 5′ cap-
dependent mechanism, and ii) recently discovered 5′ cap-indepen-
dent, internal ribosome entry site (IRES)-mediated mechanism
(Meijer and Thomas, 2002; Pickering and Willis, 2005). The IRES is a
cis-acting element that initiates protein translation through the direct
recruitment of ribosomes to an mRNA (Stoneley and Willis, 2004;
Holcik and Sonenberg, 2005; Spriggs et al., 2008). The IRES was
originally identiﬁed in virus genomes as an element that allowed
efﬁcient production of viral proteins, and subsequent studies revealedthat similar IRES sequences (termed “cellular IRES” sequences) exist
within the 5′ untranslated region (UTR) of a number of eukaryotic
cellular mRNAs (Stoneley and Willis, 2004; Holcik and Sonenberg,
2005; Spriggs et al., 2008). Functional studies demonstrated that
cellular IRES-mediated translation prevails under conditions when
cap-dependent translation is compromised, such as hypoxia, heat
shock, irradiation, apoptosis, and tumorigenesis (Stoneley and Willis,
2004; Holcik and Sonenberg, 2005; Spriggs et al., 2008). Nevertheless,
the precise roles of IRES-dependent translation under physiological
and pathological conditions remain to be determined.
Runx1 (also called AML1, CBFA2, or PEBP2α) is a transcription
factor essential for hematopoiesis and angiogenesis during embryo-
genesis (Suda and Takakura, 2001; Downing, 2003; Blyth et al., 2005;
Mikhail et al., 2006). Disruption of the Runx1 gene results in
embryonic lethality at approximately 12.5 days post-coitum (dpc),
and leads to central nervous system (CNS) hemorrhages, due to a
complete lack of deﬁnitive hematopoiesis (Okuda et al., 1996; Wang
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exhibit defects in vascular branching and remodeling, due to poor
release of angiopoietin-1 from hematopoietic stem cells (HSCs)
(Takakura et al., 2000). On the other hand, Runx1 has also been
implicated in the development of human leukemia. Runx1 is a target
of a number of leukemia-associated chromosomal translocations,
such as t(8;21)(q22;q22), t(3;21)(q26;q22), and t(12;21)(p12;q22),
which generate Runx1/ETO, Runx1/Evi1, and TEL/Runx1 fusion
proteins, respectively (Mikhail et al., 2006). In addition, point,
deletion, and insertion mutations of Runx1 have also been observed
in a signiﬁcant fraction of acute leukemias (Osato, 2004). Further-Fig. 1. Genomic organization of the Runx1 gene and generation of Runx1b knock-in (KI) m
Runx1 expression and the resulting gene products. The localizations of exons 1 and 3 and t
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The expression of Runx1 is controlled by several different
mechanisms. Transcription of Runx1 is mediated by two distinct
promoters, designated as distal promoter (P1) and proximal promoter
(P2), which are located upstream of exon 1 and exon 3, respectively
(Ghozi et al., 1996) (see Fig. 1A). Although both promoters are
transcriptionally active in both hematopoietic and non-hematopoieticice deleted with the IRES element (Runx1+/ΔIRES). (A) Regulatory elements controlling
he positions of the distal (P1) and proximal (P2) promoters and the IRES element are
es, respectively, and the IRES within the 5′ UTR of exon 3 is indicated by a gray box with
generating Runx1+/ΔIRES mice. The positions of primers and a probe for genotyping and
nx1c and Runx1b transcripts is retained, but IRES-mediated translation of the Runx1b
l of Neo resistance cassette (right panel). For ES genotyping, the KI allele-derived PCR
ts are indicated by arrows. For Neo deletion, positions of Neo-positive (Neo+) and Neo-
essages from theΔIRES allele. The RT-PCR products are indicated by arrowheads (upper
ssion of Runx1 protein. Nuclear extracts of Runx1+/+ and Runx1ΔIRES/ΔIRES embryos at
r panel).
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diverse (Ghozi et al., 1996). The distal UTR is short, contains only two
upstream ATGs (u-ATGs), and lacks GC-rich elements, whereas the
proximal UTR is unusually long, contains multiple u-ATGs, and
possesses GC-rich regions (Ghozi et al., 1996). These results strongly
suggest that the P2-derived message is much poorly transcribed as
compared to the P1-derived one. A subsequent study revealed that an
IRES element exists in the proximal UTR, just upstream of the
translation initiation ATG in exon 3 (see Fig. 1A), whose activity is
regulated during differentiation of hematopoietic cells (Pozner et al.,
2000; Levanon and Groner, 2004). Taken together, the expression of
Runx1 is regulated transcriptionally by two promoters, P1 and P2, and
also translationally by an IRES coupled with P2.
Recently, studies using P1-speciﬁc knockout (P1N/N) mice and P2-
speciﬁc knockdown (P2neo/neo) mice demonstrated that P1-dependent
Runx1 expression is not required for embryonic survival but affected
hematopoietic development and that P2-dependent Runx1 expression
is critical for deﬁnitive hematopoiesis, thymic development, and
postnatal survival (Pozner et al., 2007; Bee et al., 2010). Although
these ﬁndings provide insights into the biological roles of the distinct
expressionmachineries of the Runx1 gene, the biological signiﬁcance of
the IRES-mediated translation has not been fully understood.
In this study, to clarify the role of the IRES in Runx1 function under
physiological and pathological conditions, we generated and analyzed
knock-in mice expressing wild-type Runx1 or a Runx1 fusion protein,
in which the 5′ UTR containing the IRES element is deleted.
Materials and methods
Construction of knock-in vectors and generation of knock-in mice
The detailed procedures of construction of knock-in vectors and
generationof knock-inmice are described in Supplemental information.
Histological, immunohistochemical, and electron microscopic analyses
Histological, immunohistochemical, and electron microscopic
analyses were performed as previously described (Honda et al.,
1998). For histological analysis, serial sections (500–1000 slices per
embryo) were made and carefully observed under a microscope. For
immunohistochemical analysis, tissue sections were stained with an
anti-Runx1 antibody (ab61753, Abcam Inc. Cambridge, MA) or an
anti-SMA antibody (1A4, Dako, Glostrup, Denmark). For electron
microscopic analysis, subcutaneous vessels were subjected to ultra-
thin sectioning and examined under an electron microscope after
double staining with uranyl acetate and lead citrate.
Reverse transcription polymerase chain reaction
Total RNA was extracted from mouse tissues using TRIzol
(Invitrogen, California, CA) and mRNA was puriﬁed using Oligo-Tex
(Takara Bio Inc., Tokyo, Japan). For detecting mRNA expression of the
knock-in allele, RT-PCR was performed using mRNA extracted from
hematopoietic tissues as described previously (Miyazaki et al.,
2002). The primer sequences used for RT-PCR are shown in
Supplemental information. GAPDH RT-PCR was also performed as
an internal control. To examine Runx1 downstream target gene
expression, quantitative RT-PCR was performed as described (Maki
et al., 2005).
Western blot analysis
Nuclear extracts were isolated from whole embryos at 13.5 dpc or
16.5 dpc as previously described (Miyazaki et al., 2002). Western blot
was performed using an anti-Runx1 antibody (Active Motif, Carlsbad,
CA), ananti-Evi1 antibody (kindly providedbyDr.Morishita ofMiyazakiUniversity in Japan), or an anti-β-actin antibody (Millipore, Bedford,
USA) according to the developer's and manufacturers' instructions.
Fetal liver cell preparation and colony formation assay
Fetal livers (FLs) were separated from 12.5 dpc embryos and
mononuclear cells of each FL were collected and counted. Colony
formation assay was performed using methylcellulose supplemented
with EPO or a cocktail of cytokines as described previously (Nakahata
and Ogawa, 1982; Ma et al., 2001). All the aggregates consisting of
more than 50 cells were counted as colonies, except for magakar-
yocyte colonies, and colony types were determined on days 7 to 14 as
described previously (Nakahata and Ogawa, 1982).
Flow cytometric analysis
Flow cytometric analyses of FL cells at 12.5 dpc were performed as
reported (Ema et al., 2005; Morita et al., 2006). Detection of HSCs,
common myeloid progenitors (CMPs), granulocyte/macrophage
progenitors (GMPs), megakaryocyte/erythrocyte progenitors
(MEPs), and common lymphocyte progenitors (CLPs) was performed
using eight-parameter 6-color method with antibodies listed in
Supplemental information on a FACS Canto II (BD Biosciences, San
Jose, CA). Transplanted FL cells were analyzed with antibodies listed
in Supplemental information on a FACS Calibur (BD Biosciences, San
Jose, CA). The biotinylated antibody was developed with streptavidin
(SA)-APC-Cy7 (BioLegend, San Diego, CA).
Analysis of apoptosis and cell cycle status
FL cells were prepared from 12.5 dpc embryos. 4.5×104 cells were
cultured inαMEM(Sigma) containing20%FBS, 100 ng/ml SCF, 10 ng/ml
IL-3 and 10 ng/ml IL-6. Lineage-negative (lin−), c-kit-positive (c-kit+)
cells were isolated using antibodies listed in Supplemental information.
For detecting apoptotic cells, lin−c-kit+ cells were stained with anti-
Annexin V-FITC and Annexin V+ cells were analyzed using the Annexin
V-FITC Apoptosis detection kit II, according to the manufacturer's
instructions (BDBiosciences). For determining cell cycle status, lin−c-
kit+ cells were stained with propidium iodide (PI), and the amount of
nuclear DNA was measured using the CycleTEST PLUS DNA Reagent Kit,
according to the manufacturer's instructions (BD Biosciences).
Competitive repopulation assay of FL cells
Competitive repopulationassaywasperformedusing theLy5congenic
mouse system. 2×105 FL cells from Runx1+/+ or Runx1ΔIRES/ΔIRES
embryos (Ly5.2+) at 13.5 dpc were mixed with the same number of FL
cells from a wild-type Ly5.1+ embryo at the same age and were
transplanted into irradiated (9.5 Gy) Ly5.1+ recipient mice. Peripheral
blood cells of the recipient mice were stained with anti-Ly5.1 and anti-
Ly5.2 antibodies (see Supplemental information) for the percentage of
Ly5.2+ cells at 4, 8, and 12 weeks after transplantation. At 12 weeks after
transplantation, the percentage of Ly5.2+ cells was also analyzed on the
thymus, spleen, and bone marrow in addition to the peripheral blood
using anti-Ly5.1, anti-Ly5.2, and other lineage-speciﬁc antibodies (see
Supplemental information).
Results
Generation of wild-type Runx1 knock-in mice deleted with the
IRES element
A schematic representation of the regulatory elements controlling
Runx1 expression at the level of transcription and translation is
shown in Fig. 1A. A message transcribed from the P1 contains exon 1,
which is spliced into the coding region of exon 3 to produce Runx1c,
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Runx1b, which can be translated in both cap-dependent and IRES-
mediatedmanners.We ﬁrst investigated the role of the IRES in normal
Runx1 function, by generating wild-type Runx1 knock-in mice, in
which a part of the 5′ UTR containing the IRES element was deleted.
For this purpose, the coding region of exon 3 and part of intron 3 were
replaced with the complete human Runx1b cDNA (hRunx1b) fused at
the 3′ end to a polyadenylation signal (pA) and ﬂanked by two loxP
sites, where the ﬁrst loxP was designed to disrupt the IRES sequences
(Fig. 1B). In these mice, the wild-type Runx1 was expressed by both
the P1 and P2, but not by the IRES.
ES cells with homologous recombination, identiﬁed by 5′
genomic PCR and 3′ Southern blot (Fig. 1C, left and middle panels),
were used to generate the knock-in mice (Runx1+/KI). The Neo
resistance gene was removed by the Flpe recombinase so as to avoid
any effects of the Neo promoter on Runx1 expression (Fig. 1C, right
panel). In the resultant mice (Runx1+/ΔIRES), as shown in Fig. 1B, P1-
dependent Runx1c expression was retained, since the splicing
acceptor site was conserved in the hRunx1b cDNA, and P2-
dependent Runx1b expression was also unaffected, but IRES-
dependent translation of the latter message was eliminated. The
expression of the RNAs transcribed from the P1 and P2 within the
knock-in allele was conﬁrmed by performing reverse transcription
polymerase chain reaction (RT-PCR) using primers derived from
exons 1 (mRunx1c) and 3 (mRunx1b) along with a primer speciﬁc
for hRunx1b (hRunx1-4) that does not anneal to the endogenous
mouse Runx1 message (Fig. 1D). The expression of Runx1 protein in
Runx1+/+ and Runx1ΔIRES/ΔIRES mice was examined by blotting
nuclear extracts of whole embryos with an anti-Runx1 antibody. As
shown in Fig. 1E, comparable amount of Runx1 protein was
detected in both types of mice. To further examine the distribution
and amount of Runx1 protein in Runx1+/+ and Runx1ΔIRES/ΔIRES
embryos, sagittal sections of the embryos were immunohistochemi-
cally stained with an anti-Runx1 antibody. As shown in Supple-
mental Fig. 1, similar staining pattern and intensity were observed
in both types of embryos. These results indicated that IRES
deﬁciency did not signiﬁcantly affect Runx1 protein expression
during embryonic development.
Homozygotes expressing wild-type Runx1 deleted for the IRES
(Runx1ΔIRES/ΔIRES) died in utero at around 14.5 dpc, exhibiting vessel
dilatation, subcutaneous edema, and pale liver
Heterozygous mice (Runx1+/ΔIRES) were indistinguishable from
their wild-type littermates and were intercrossed to obtain
homozygous mutants (Runx1ΔIRES/ΔIRES). No live Runx1ΔIRES/ΔIRES
mice were born, indicating that mice with deletion of the IRES
element were embryonic lethal. Timed pregnancy revealed that
Runx1ΔIRES/ΔIRES mice died in utero at approximately 14.5 dpc
(Supplemental Table 1).
The representative macroscopic appearances and HE-stained
sagittal sections of Runx1+/+ and Runx1ΔIRES/ΔIRES embryos at
13.5 dpc are shown in Fig. 2A. As compared to Runx1+/+ embryo,
Runx1ΔIRES/ΔIRES embryo exhibited marked vessel dilatation mainly in
the trunk, subcutaneous edema, and pale liver (indicated by arrows, an
arrowhead, and a white triangle, respectively, in the right panels of
Fig. 2A).
The results of microscopic analyses are shown in Fig. 2B. In
contrast to the normal peripheral blood vessels of Runx1+/+ mice
(indicated by arrowheads in the left upper panel of Fig. 2B), those of
Runx1ΔIRES/ΔIRES mice were markedly dilated and occasionally formed
microaneurysms with hemorrhage (indicated by arrows in the right
upper panel of Fig. 2B). In addition, as shown in the right middle panel
of Fig. 2B, the subcutaneous region of Runx1ΔIRES/ΔIRES was highly
edematous (shown as “Edema”) and was associated with vessel
dilatation and bleeding (indicated by an arrow). On the other hand, noobvious difference in blood vessel formation was observed in major
internal organs of Runx1+/+ and Runx1ΔIRES/ΔIRES embryos, such as
the brain (indicated by arrowheads in the lower panels of Fig. 2B).
Capillary-associated pericytes were poorly developed in
Runx1ΔIRES/ΔIRES mice
To investigate the mechanism(s) underlying vascular dilatation,
capillaries were immunohistochemically stained with antibodies
against vessel-related molecules. An antibody against α-smooth
muscle actin (SMA) that detects pericytes gave rise to distinct
differences in staining in Runx1+/+ and Runx1ΔIRES/ΔIRES embryos,
which correlated well with the distribution of vascular dilatation.
Normal subcutaneous capillaries of Runx1+/+ embryos were clearly
stained with the anti-SMA antibody (indicated by arrowheads in the
left upper panel of Fig. 2C), whereas the abnormally dilated
subcutaneous vessels in Runx1ΔIRES/ΔIRES embryos were only faintly
stained with the same antibody (indicated by arrows in the right
upper panel of Fig. 2C). In contrast, capillaries in major organs, such
as the brain, were stained to a similar extent with this antibody in
both types of embryos (indicated by arrowheads in the lower panels
of Fig. 2C). These results strongly suggested that dysfunction of
capillary-associated pericytes was responsible for the vascular
dilatation observed in Runx1ΔIRES/ΔIRES embryos. To investigate
possible structural changes in the pericytes of the mutant mice,
the subcutaneous peripheral blood vessels of Runx1+/+ and
Runx1ΔIRES/ΔIRES embryos were subjected to electron microscopic
analysis. As shown in Fig. 2D, in contrast that the pericytes of
Runx1+/+ mice tightly attached and surrounded the endothelial
cells (left panel), those of Runx1ΔIRES/ΔIRES mice were poorly
developed, partly detached from the endothelial cells, and invagi-
nated into the vessels (right panel). To ascertain whether Runx1 is
expressed in pericytes, small and large vessels of Runx1+/+
embryos were stained with an anti-Runx1 antibody. As shown in
Fig. 2E, positive staining was detected in a cell morphologically
resembling a pericyte and surrounding a capillary (indicated by an
arrow in the right panel) but was not observed in a cell
morphologically resembling a smooth muscle cell and lining inferior
vena cava (indicated by an arrowhead in the right panel). These
results indicate that Runx1 is preferentially expressed in pericytes
among vessel-surrounding cells and that IRES-mediated Runx1
expression is essential for peripheral blood vessel integrity through
effects on normal pericyte development and function during
embryogenesis.
Marked reduction, altered differentiation, increased apoptosis, and
decreased cell cycle of Runx1ΔIRES/ΔIRES FL hematopoietic cells
The Runx1ΔIRES/ΔIRES FL was hardly detectable through the skin
(indicated by a white triangle in the right panels of Fig. 2A) and
macroscopically looked very pale (right upper panel of Fig. 3A).
Microscopic analysis revealed that Runx1ΔIRES/ΔIRES FL contained a
signiﬁcantly reduced number of hematopoietic cells, as compared to
Runx1+/+ FL (indicated by arrows in the right lower panel of Fig. 3A).
Themarked reduction in cell numberwas further demonstrated by cell
counting of Runx1+/+, Runx1+/ΔIRES, and Runx1ΔIRES/ΔIRES FLs
(Fig. 3B).
We then investigated the differentiation status of Runx1+/+ and
Runx1ΔIRES/ΔIRES FL hematopoietic cells. A detailed FACS analysis using a 6-
colored method was applied, which detects hematopoietic cells with
various differentiation stages, including hematopoietic stem cell (HSC),
commonmyeloid progenitor (CMP), granulocyte/macrophage progenitor
(GMP), megakaryocyte/erythrocyte progenitor (MEP), and common
lymphocyte progenitor (CLP) fractions. As shown in Fig. 3C, although
the total cell number in Runx1ΔIRES/ΔIRES FL was signiﬁcantly reduced as
compared to that in Runx1+/+ FL, all the fractions were present in both
Fig. 2. Pathological analyses of Runx1+/+ and Runx1ΔIRES/ΔIRES embryos. (A) Macroscopic appearances (upper panels) and HE-stained sagittal sections (lower panels) at 13.5 dpc.
Prominently dilated subcutaneous blood vessels and subepidermal edema are indicated by arrows and an arrowhead, respectively, and pale liver is indicated by awhite triangle (also
see Fig. 3A). (B) HE-stained tissue sections at 13.5 dpc. Normal and dilated capillaries are indicated by arrowheads and arrows, respectively. In the skin sections (body and back,
upper andmiddle panels), vascular dilatation with hemorrhage and subepidermal edema (Edema) are apparent in Runx1ΔIRES/ΔIRES embryos. In contrast, in the brain sections (lower
panels), no dilated vessels are observed in both types of embryos. Epi, epidermis; SC, spinal cord. (C) Immunohistochemical staining with an anti-SMA antibody at 13.5 dpc. In the
skin sections (body, upper panels), positive staining is detected around normal capillaries in Runx1+/+ embryos (indicated by arrowheads), whereas no staining is observed around
the dilated capillaries (indicated by dotted lines) in Runx1ΔIRES/ΔIRES embryos (indicated by arrows). In contrast, in the brain sections (lower panels), staining of a similar intensity is
observed in both types of embryos (indicated by arrowheads). Epi, epidermis. (D) Electron microscopic analysis of capillaries at 13.5 dpc. In a Runx1+/+ capillary, a pericyte (Peri)
tightly attaches and surrounds an endothelial cell (End) (left panel). In contrast, in a Runx1ΔIRES/ΔIRES capillary, pericytes are partly detached from endothelial cells (indicated by
arrowheads in the right panel) and are invaginated into vessels with enlarged pinocytotic vesicles (indicated by asterisks in the right panel). Ery, erythrocyte. (E) Immunohistochemical
staining with an anti-Runx1 antibody at 14.5 dpc. The boxed area in the left panel is magniﬁed in the right panel. In the right panel, positive staining is detected in a pericyte-like cell
surrounding a capillary (indicated by an arrow) but not observed in a smooth muscle-like cell lining inferior vena cava (IVC) (indicated by an arrowhead).
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(2.08% in Runx1+/+ FL and 3.81% in Runx1ΔIRES/ΔIRES FL, Fig. 3C upper
panels), whereas a decrease in MEP fraction and an increase in CMP and
GMP fractions were observed in Runx1ΔIRES/ΔIRES FL as compared to
Runx1+/+ FL (percentages of Runx1+/+ FL and Runx1ΔIRES/ΔIRES FL
were; 94.9% and 41.6% forMEP, 3.04% and 30.2% for CMP, and 0.53% and
3.1% for GMP, Fig. 3C middle panels). As for CLP, although a slightFig. 3. Hematopoietic analysis of Runx1+/+ and Runx1ΔIRES/ΔIRES FLs. (A)Macroscopic appearances
at 12.5 dpc. As compared to Runx1+/+ FL, Runx1ΔIRES/ΔIRES FL is pale and contains signiﬁcantly redu
amongRunx1+/+, Runx1+/ΔIRES, and Runx1ΔIRES/ΔIRES embryos at 12.5 dpc. Data are plotted asmea
(pb0.01). (C) Flow cytometric analysis of HSC and progenitor fractions of Runx1+/+ and Runx1
macrophage progenitor; CMP, common myeloid progenitor; and CLP, common lymphocyte proge
fractionsbutadecrease inMEP fraction. (D)Apoptotic state andcell cycleproﬁle of theRunx1+/+an
means with error bars. As compared to Runx1+/+ FL, Runx1ΔIRES/ΔIRES FL shows an increase in Ann
panel, p=0.07).increasewas observed in Runx1ΔIRES/ΔIRES FL (7.17% in Runx1+/+ FL and
19.4% in Runx1ΔIRES/ΔIRES FL, Fig. 3C lowerpanels), thedifferencewasnot
reproducible, due to the limited number of cells present in this fraction
at this stage.
We next analyzed the apoptotic state and cell cycle proﬁle of the
Runx1+/+ and Runx1ΔIRES/ΔIRES FL hematopoietic stem/early progen-
itor cells. Lineage-negative (lin−), c-kit-positive (c-kit+) cells were(upper panels) andHE-stained sections (lower panels) of Runx1+/+ and Runx1ΔIRES/ΔIRES FLs
ced number of hematopoietic cells (indicated by arrows). (B) Comparison of FL cell numbers
nswith error bars. A signiﬁcant reduction in the cell number is observed in Runx1ΔIRES/ΔIRES FL
ΔIRES/ΔIRES FLs at 12.5 dpc. MEP, megakaryocyte/erythrocyte progenitor; GMP, granulocyte/
nitor. As compared to Runx1+/+ FL, Runx1ΔIRES/ΔIRES FL shows an increase in GMP and CMP
dRunx1ΔIRES/ΔIRES FLhematopoietic stem/earlyprogenitor cells at12.5 dpc.Dataareplottedas
exin V+ apoptotic cells (upper panel, p=0.15) and a decrease in S-G2/M cycling cells (lower
231A. Nagamachi et al. / Developmental Biology 345 (2010) 226–236isolated from Runx1+/+ and Runx1ΔIRES/ΔIRES FLs, stained with
Annexin V or propidium iodide (PI), and analyzed by FACS. As
shown in Fig. 3D, as compared to lin−c-kit+ cells of Runx1+/+ FL,those of Runx1ΔIRES/ΔIRES FL exhibited an increase in the percentage of
apoptotic Annexin V+ cells (upper panel) and a decrease in the
proportion of cycling (S-G2/M phase) cells (lower panel), although
232 A. Nagamachi et al. / Developmental Biology 345 (2010) 226–236the differences were not statistically signiﬁcant (p=0.15 for
apoptotic analysis and p=0.07 for cell cycle analysis).
These results indicated that IRES-mediated Runx1 expression is
pivotal in expansion of FL hematopoietic cells and affected differen-
tiation, apoptotic status, and cell cycle proﬁle.Reduced colony formation activity and altered expression of
downstream target genes in Runx1ΔIRES/ΔIRES FL hematopoietic cells
We then rigorously evaluated the proliferative potential of
Runx1ΔIRES/ΔIRES FL hematopoietic cells. We ﬁrst examined the colony-
forming activity by culturing FL hematopoietic cells of Runx1ΔIRES/ΔIRES
mice and their control (Runx1+/+ and Runx1+/ΔIRES) littermates with
various cytokines. As shown Table 1, hematopoietic CFUs generated from
Runx1ΔIRES/ΔIRES FL cells were markedly reduced as compared to those
from control littermates. A signiﬁcant decrease (80–90%)
was observed in CFU-E and CFU-Mix colonies, while the reduction
of BFU-E and CFU-GM colonies was less remarkable (~50%). In
addition, although single megakaryocytes were occasionally observed,
no megakaryocytic colonies were generated from Runx1ΔIRES/ΔIRES FLs.
Moreover, Runx1ΔIRES/ΔIRES FL-derived colonies were smaller and
contained fewer cells than control FL-derived colonies (Supplemental
Fig. 2).
To investigate the molecular mechanisms underlying the altered
proliferative activity in Runx1ΔIRES/ΔIRES FLs, we examined the expression
patterns of Runx1 downstream target genes implicated in deﬁnitive
hematopoiesis. RNAs extracted from Runx1+/+ and Runx1ΔIRES/ΔIRES FLs
were subjected to quantitative RT-PCR analysis. The expression levels of
the indicated genes in Runx1ΔIRES/ΔIRES FL relative to those in Runx1+/+ FL
are shown in Fig. 4. Although all the genes examined were expressed in
both Runx1+/+ and Runx1ΔIRES/ΔIRES FLs, the expression levels varied
among genes. Enhanced expressionwas detected for CEBPα, M-CSFR, and
G-CSFR,while reducedexpressionwasobserved forNFE2,β-globin, ALAS-
E, and MPO in Runx1ΔIRES/ΔIRES FL as compared to Runx1+/+ FL.Impaired repopulation ability of Runx1ΔIRES/ΔIRES FL cells in the
competitive repopulation assay
We nest investigated the in vivo repopulation ability of
Runx1ΔIRES/ΔIRES FL cells, by performing the competitive repopula-
tion assay using the Ly5 congenic mouse system. Irradiated Ly5.1+
mice were transplanted with FL cells from a Runx1+/+ or a
Runx1ΔIRES/ΔIRES embryo (Ly5.2+) together with the same number of
FL cells fromawild-type Ly5.1+ embryoof the sameage. Engraftment of
the Runx1+/+ or Runx1ΔIRES/ΔIRES FL-derived cells was analyzed by ﬂow
cytometry and the repopulation ratio was assessed as the percentage of
Ly5.2+ cells in the peripheral blood (PB) (4, 8, and 12 weeks after
transplantation) and in the hematopoietic tissues (12 weeks after
transplantation). The analysis of the PB showed that the overall
reconstitution ability of Runx1ΔIRES/ΔIRES FL was signiﬁcantly reduced
as compared to that of Runx1+/+ FL (left panel of Fig. 5A). Interestingly,
while the reconstitution ability in granulocytes was not signiﬁcantly
affected (middle panel of Fig. 5A), that in lymphocytes was severely
impaired (right panel of Fig. 5). In addition, the analysis of the
hematopoietic tissues exhibited poor contribution of Runx1ΔIRES/ΔIRES
FL cells, especially in the thymus and spleen (left panel of Fig. 5B). The
cell lineage-speciﬁc analyses in the thymus, spleen, and BM revealed
that Runx1ΔIRES/ΔIRES FL cells possessed a comparable reconstitution
ability in myelomonocytic and megakaryocytic lineages (Gr1+, Mac1+,
and CD61+ in the right panel of Fig. 5B), but exhibited a remarkably
reduced reconstitution ability in T- and B-lymphoid lineages (Thy1.2+
and B220+ in the right panel of Fig. 5B). These results indicated that the
repopulation ability of Runx1ΔIRES/ΔIRES FL hematopoietic cells was
impaired, especially in the lymphoid lineages.Heterozygotes expressing Runx1/Evi1 deleted with the IRES element
were normally born and did not show any hematological abnormalities
We ﬁnally investigated the role of the IRES in leukemogenesis
mediated by the expression of Runx1-fusion proteins. Runx1/Evi1 (RE),
a Runx1 fusion protein created by t(3;21)(q26;q22) in human leukemia
(Mitani et al., 1994), was knocked into the Runx1 locus, using a similar
knock-in strategy aswas used to generate Runx1+/ΔIRES, except that the
Runx1/Evi1 cDNA fused to the pA was preceded by a ﬂoxed Neo
resistance cassette (Fig. 6A). We generated RE knock-in mice, following
removal of the Neo resistance cassette from the recombinant ES cells by
Cre recombinase. The P1-derived RE message was expressed in these
mice, since the splice acceptor site was conserved in the Runx1 region
of RE. In addition, P2-dependent RE expression was unaffected, but
IRES-dependent RE expression was eliminated (Runx1+/REΔIRES,
Fig. 6A).
Correctly targeted ES cells identiﬁed by 5′ genomic PCR and 3′
Southern blot (Fig. 6B, left and middle panels) were used to generate
knock-in mice following removal of the Neo resistance gene (Fig. 6B,
right panel). The expression of the REmRNAs from both the P1 and P2
promoters was conﬁrmed by RT-PCR, using the samemethods as used
for the analysis of expression in the Runx1+/REΔIRES mice (Fig. 6C). In
addition, expression of RE protein in Runx1+/REΔIRES mice was
detected by Western blot (Fig. 6D).
Interestingly, in contrast to the conventional RE knock-in mice,
which died in utero exhibiting CNS hemorrhage due to a dominant
negative effect of RE on endogenous Runx1 function (Maki et al., 2005),
Runx1+/REΔIRES mice were born at the expected Mendelian ratio without
any phenotypical defects (data not shown). In addition, no obvious
differences in hematopoietic parameters were found between Runx1+/+
and Runx1+/REΔIRES mice during a long-term observation period (Fig. 6E),
in contrast that conventional RE knock-in chimeric mice develop
megakaryocytic leukemia (Maki et al., 2006). These results demonstrated
that IRES-mediatedREexpressionwas required for thedominantnegative
activity during embryogenesis and the leukemogenic potential in adult
hematopoiesis.
Discussion
Runx1 is a gene whose expression is regulated transcriptionally by
two distinct promoters (P1 and P2), giving rise to two different
mRNAs, and also translationally by an IRES element, existing just
upstream of the translation initiation codon of P2-derived mRNA
(Pozner et al., 2000; Levanon and Groner, 2004). In this study, we
applied a knock-in strategy to clarify the biological role(s) of the IRES
sequences in normal Runx1-mediated hematopoiesis and angiogen-
esis and also in mutated Runx1-induced leukemogenesis.
We ﬁrst generated knock-in mice of Runx1b, the predominant
transcript of the Runx1 gene, in which promoter-dependent transcrip-
tion was retained but IRES-medicated translation was eliminated. A
number of Runx1mRNAs are produced by alternative splicing (Levanon
et al., 2001), while Runx1ΔIRES/ΔIRES mice generated Runx1c and IRES-
disrupted Runx1b transcripts (Fig. 1B), raising the possibility that the
phenotypes of our mutant mice might be due to the lack of the splice
variants. However, our previous study demonstrated thatmice contain-
ingRunx1b cDNAknocked into exon4of the Runx1 gene,which express
Runx1c and Runx1b, developed normally and did not show any obvious
defects (Okuda et al., 2000). Thus, the expression of Runx1c and Runx1b
without other spliced forms is shown to be sufﬁcient for the proper
mouse development. The major difference in the regulatory elements
controlling Runx1 expression between our previous and current studies
is that Runx1b mRNA in this study lacks the IRES element. Therefore,
the abnormal phenotypes observed in Runx1ΔIRES/ΔIRES mice are
considered not due to the lack of alternatively spliced forms but to
the lack of IRES-mediated Runx1 expression. However, as compared to
the knock-in mice in our previous study (Okuda et al., 2000),
Table 1
Hematopoietic colony-forming activity of Runx1+/+, Runx1+/ΔIRES, and Runx1ΔIRES/ΔIRES fetal livers.
Genotype Cell counts/liver
(×105)
Absolute number per fetal liver
CFU-E BFU-E CFU-Meg CFU-GM CFU-Mix Total CFU-cells
+/+ 12.60±7.5 (n=4) 58867 2495 1373 14301 2003 79040 (n=4)
+/ΔIRES 13.67±7.2 (n=17) 59054 2556 1080 16021 3158 81883 (n=5)
ΔIRES/ΔIRES 2.02±0.6 (n=7) 3024 1091 0 7123 436 11684 (n=6)
Ratio for cut-down
+ = + −ΔIRES =ΔIRES
+ = +
  84.0% 94.9% 56.3% 100% 50.2% 78.2% 85.2%
1×104 MNCs from each single fetal liver at 12.5 dpc were initially plated in 1 ml semisolid cultures with cytokine cocktail.
Colony types and numbers were determined at days 10 to 15 in the culture. Table shows converted absolute CFU cell numbers per fetal liver.
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there remains the possibility that intron 3 contains an element with an
enhancer activity that affects Runx1 function.
Runx1ΔIRES/ΔIRES mice died in utero at around 14.5 dpc (Supplemen-
tal Table 1) with prominently dilated peripheral capillaries, severe
subepidermal edema, and pale liver (Figs. 2A and B), which demon-
strated the indispensable role of the IRES element in embryonic
development. To investigate the effect of the deletion of the IRES on
Runx1 expression, we performed western blot and immunohistochem-
ical staining of Runx1+/+ and Runx1ΔIRES/ΔIRES embryos. As shown in
Fig. 1E and Supplemental Fig. 1, both types of embryos exhibited
comparable amounts and similar distributionpatterns of Runx1 protein,
indicating that IRES deﬁciency did not signiﬁcantly affect the Runx1
protein expression. This ﬁnding led us to the idea that IRES-mediated
Runx1 expressionmight be essential in a speciﬁc developmental stage, a
particular cell lineage and/or a critical point of cell cycle, as suggested in
previous studies (Mitchell et al., 2003; Gonzalez-Herrera et al., 2006;
Audigier et al., 2008; Dobbyn et al., 2008; Jo et al., 2008).
Interestingly, the phenotype anddeathperiod of Runx1ΔIRES/ΔIRESmice
differ from those of Runx1 full-knockout (Runx1−/−) mice. Runx1−/−
micedie of CNShemorrhage at around12.5 dpc (Okudaet al., 1996;Wang
et al., 1996;Okada et al., 1998),whereas Runx1ΔIRES/ΔIRESmice survive this
stage and presumably die of circulation failure at around 14.5 dpc.
Although the reason for the phenotypical and temporal differences in the
embryonic lethality of these mutant mice is not clear yet, it could be
postulated that P1- and P2-derived Runx1 expression in a cap-dependent
fashion rescues Runx1ΔIRES/ΔIRES mice from the fatal CNS hemorrhage at
earlier stages but cannot prevent vessel dilatation, ﬂuid leakage and
circulation failure at later stages, when IRES-mediated Runx1 expressionFig. 4. Expression changes of Runx1 downstream target genes. RNAs extracted from Runx
expression levels of the genes in Runx1ΔIRES/ΔIRES FL relative to those in Runx1+/+ FL are shis absolutely required. In addition, it is intriguing that Runx1ΔIRES/ΔIRES
mice die earlier thanP2-speciﬁc knockdown(P2neo/neo)mice that develop
to term (Pozner et al., 2007; Bee et al., 2010), since the IRES is coupled to
P2-derivedmRNA (Fig. 1A). One possible explanation for this discrepancy
is that P2 activity is not completely eliminated in the knockdown system
and the residual P2-derived transcript rescues P2neo/neo embryos from
fatal vessel dilatation and systemic edema observed in Runx1ΔIRES/ΔIRES
embryos.
It is of note that the blood vessel dilatation in Runx1ΔIRES/ΔIRES mice
was prominent in the trunk but was not observed in major organs,
such as the brain (Figs. 2A and B). These results indicated that the
Runx1 IRES plays a region-preferential role in vascular development.
The underlying mechanism is not clear, but one possibility is the
difference in the oxygen partial pressure (PO2) among organs. A
previous report showed that during embryonic development, the
mean PO2 in the head is signiﬁcantly higher than that in the trunk
(Meuer et al., 1992). Given that IRES-mediated translation predomi-
nates under hypoxic conditions (Stoneley andWillis, 2004; Holcik and
Sonenberg, 2005), it could be postulated that IRES-mediated Runx1
expression plays a more substantial role in the trunk than in the brain,
which underlies the peripheral tissue-predominant vascular dilata-
tion in Runx1ΔIRES/ΔIRES mice.
The immunohistochemical analysis showed that Runx1 is preferen-
tially expressed in capillary-associated pericytes (Fig. 2E) and the electron
microscopic analysis revealed that pericytes in Runx1ΔIRES/ΔIRES embryos
were poorly developed (Fig. 2D). Pericytes surround the vascular
endothelial cells and maintain the integrity of blood vessels (Kubo and
Alitalo, 2003). In addition, pericytes produce angiopoietin-1, a factor
promoting angiogenesis by binding to Tie2 receptors expressed on1+/+ and Runx1ΔIRES/ΔIRES FLs at 12.5 dpc were subjected to quantitative RT-PCR. The
own. Data are plotted as means of three independent mice.
Fig. 5. Repopulation ability of Runx1+/+ and Runx1ΔIRES/ΔIRES FL cells. (A) Contribution of donor-derived cells to the peripheral blood of the recipient mice at 4, 8, and 12 weeks after
transplantation. The percentages of Runx1+/+ (white boxes) and Runx1ΔIRES/ΔIRES (black boxes) cells (Ly5.2+) in the total WBCs, granulocytes, and lymphocytes are shown. Data are
plotted as means with error bars. (B) Contribution of donor-derived cells to the thymus (Thy), spleen (Spl), and bone marrow (BM) of the recipient mice at 12 weeks after
transplantation. The percentages of Runx1+/+ (white boxes) and Runx1ΔIRES/ΔIRES (black boxes) cells (Ly5.2+) in the thymus, spleen, and bone marrow (left panel) and in various
hematopoietic lineages in these tissues (right panel) are shown. Data are plotted as means with error bars.
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vessel formation through structurally stabilizing vascular architecture and
functionally promoting vascular remodeling. These ﬁndings strongly
suggest that Runx1 plays an important role in pericyte development, as
suggested inprevious studies (Lacaudet al., 2002;Kubo andAlitalo, 2003)
and thatRunx1 IRESdeﬁciencydirectly impairedpericyte functionand led
to the vascular abnormalities observed in Runx1ΔIRES/ΔIRES mice.
Another remarkable aspect of Runx1ΔIRES/ΔIRES mice was pale liver,
due to a signiﬁcant reduction of hematopoietic cells (Figs. 2A and 3A
and B). This ﬁnding indicated that IRES-mediated Runx1 expression is
pivotal not only for vascular development but also for FL hematopoi-
esis. The mechanism underling the reduction of Runx1ΔIRES/ΔIRES FL
hematopoietic cells is not clear, but Runx1ΔIRES/ΔIRES hematopoietic
stem/early progenitor cells exhibited an increased ratio of apoptosis
and a decreased ratio of cell cycling (Fig. 3D). Therefore, it seems likely
that these abnormalities would be, at least partly, responsible for the
poor proliferation of Runx1ΔIRES/ΔIRES FL hematopoietic cells.
It is to be noted that the differentiation and proliferation
activities of Runx1ΔIRES/ΔIRES FL cells varied among hematopoietic
lineages. In the FACS analysis, the MEP fraction was markedly
decreased, whereas the CMP and GMP fractions were relatively
increased (Fig. 3C). In addition, in the colony formation assay,
colony numbers of CFU-E and CFU-Meg were more signiﬁcantly
reduced than that of CFU-GM (Table 1). Quantitative RT-PCR
analysis revealed that expression patterns of Runx1 target genes
were altered in the Runx1ΔIRES/ΔIRES FL (Fig. 4). Downregulation of
erythroid- and megakaryo-related genes (NFE2, β-globin, ALAS-E,and MPO) would be responsible for the marked reduction in MEP
fraction and CFU-E and CFU-Meg colonies, and upregulation of
myeloid- and macrophage-related genes (CEBPα, M-CSFR, and G-
CSFR) would account for the less signiﬁcant reduction of CMP and
GMP fractions and CFU-GM colony. Moreover, in a competitive
repopulation assay, Runx1ΔIRES/ΔIRES FL cells differentiated into
myeloid lineages to a similar extent as Runx1+/+ FL cells, but
contributed to lymphoid lineages to a much lesser extent (Fig. 5).
These results indicated that IRES-mediated Runx1 expression plays
an essential role in expansion and differentiation of lymphoid cells.
Interestingly, hematopoietic cells of Runx1 conditional knockout
mice showed a similar phenotype; in the competitive repopulation
assay, hematopoietic cells with acquired Runx1 ablation possessed
an ability of myeloid differentiation but exhibited almost a
complete lack of lymphoid differentiation (Ichikawa et al., 2004;
Growney et al., 2005; Putz et al., 2006). These results strongly
suggest that IRES-mediated expression plays substantial roles in
Runx1 function not only in embryonic development but also in
adult hematopoiesis.
We ﬁnally investigated the pathological role of the IRES in mutated
Runx1-induced leukemia, by generating Runx1/Evi1 (RE) knock-in
mice, in which promoter-dependent transcription was retained but
IRES-mediated translation was eliminated (Runx1+/REΔIRES). Interest-
ingly, although the RE protein was expressed in Runx1+/REΔIRES mice
(Fig. 6D), probably by a cap-dependent mechanism, the mice were
normally born and did not exhibit any hematopoietic abnormalities
during a long-term observation period (Fig. 6E). These results contrast
Fig. 6. Generation and analysis of Runx1/Evi1 (RE) knock-in mice deleted with the IRES element (Runx1+/REΔIRES). (A) Strategy for generating Runx1+/REΔIRES mice. The knock-in
strategy was essentially the same as that used in generating Runx1+/ΔIRES embryos (Fig. 1B). In the Runx1+/REΔIRES mice, P1- and P2-dependent RE transcription was retained, but
IRES-mediated RE translation was eliminated. (B) Results of ES genotyping (left and middle panels) and removal of Neo resistance cassette (right panel). For ES genotyping, a
positive PCR product for 5′ PCR is indicated by an arrowhead, and positions of germline (GL)- and KI-derived fragments for 3′ Southern blot are indicated by arrows. For Neo deletion,
positions of Neo-positive (Neo+) and Neo-deleted (ΔNeo) PCR products are indicated by arrows. (C) RT-PCR analysis of the mRNA expression from the REΔIRES allele. The RT-PCR
products are indicated by arrowheads (upper panels) and the GAPDH RT-PCR was performed as an internal control (lower panels). (D) Expression of RE protein. Nuclear extracts of
Runx1+/+ and Runx1+/REΔIRES at 16.5 dpc were blotted with an anti-Evi1 (upper panel) or an anti-β-actin antibody (lower panel). (E) Changes in peripheral blood cell parameters in
Runx1+/+ (white boxes) and Runx1+/REΔIRES (black boxes) mice at 4, 8, 12, and 16 months of age. Data are plotted as means with error bars.
235A. Nagamachi et al. / Developmental Biology 345 (2010) 226–236previous studies that showed conventional RE knock-in heterozygotes
died in utero at around 12.5 dpc due to CNS hemorrhage and RE knock-
in chimeric mice developed megakaryoblastic leukemia (Maki et al.,
2005; Maki et al., 2006). Therefore, although we did not directly
compare the expression level of RE protein in the hematopoietic
compartment between Runx1+/REΔIRES and conventional RE knock-inmice, these results indicate that IRES-mediated translation is required
for RE to exert its dominant negative activity during embryogenesis and
leukemogenic potential in adult hematopoiesis.
In this study,we investigated the biological roles of the IRES element
in the Runx1 gene and demonstrated that the region is essential for
normal Runx1-mediated angiogenesis and hematopoiesis and also for a
236 A. Nagamachi et al. / Developmental Biology 345 (2010) 226–236Runx1 fusion protein-induced leukemogenesis. These results provide
novel insights into the in vivo function of an IRES under physiological
and pathological conditions, and demonstrate that this IRES-ablating
gene targeting will ﬁnd application in the elucidation of the biological
roles of various cellular IRESes. In addition, since IRES-mediated
translation has been shown to play an important role in tumorigenesis
(Stoneley and Willis, 2004), our results raise the possibility that Runx1
IRES could be regarded as a potential therapeutic target for mutated
Runx1-induced hematopoietic malignancies.
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